Annual Drug Patent Expirations for FERAHEME
Feraheme is a drug marketed by Covis and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for FERAHEME.
This drug has eleven patent family members in ten countries.
The generic ingredient in FERAHEME is ferumoxytol. One supplier is listed for this compound. Additional details are available on the ferumoxytol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
